Clinical Trial Update: Fidaxomicin to Prevent Clostridium Difficile Colonization [Phase 4]

View source ↗

Summary

Phase 4 trial of fidaxomicin to prevent Clostridioides difficile infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Dificid (fidaxomicin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Clostridium Difficile Infection | Phase 4 | Status: WITHDRAWN